Cell Therapy Raw Materials Top Companies and Strategic Involvements
The global cell therapy raw materials market is valued at US$ 5.43 billion in 2024, increasing to US$ 6.75 billion in 2025, and is expected to reach approximately US$ 48.54 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 24.5% from 2025 to 2034.
Top Companies in the Cell Therapy Raw Materials
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher
- Sartorius Stedim Biotech
- Actylis.
- ACROBiosystems
- STEMCELL Technologies.
- Grifols, S.A.
- Charles River Laboratories
- RoosterBio, Inc.
- PromoCell GmbH
Shipping and Consignee Information in U.S. for Cell Therapy Raw Materials (2023 - 24)
| CONSIGNEE_NAME | SHIPPER_NAME | HS_CODE | SUMOFQUANTITY |
| E AND J GALLO | TOYO SEIKAN CO LIMITED | 847950 | 4151936 |
| FRESENIUS KABI LLC | HP HALDEN PHARMA AS SVINESUNDSVEIEN | 300190 | 1231080 |
| EUCATEX OF NORTH AMERICA INC | EUCATEX INDUSTRIA E COMERCIO LTDA | 382200 | 901730 |
| LIFESCAN GLOBAL CORP | LIFESCAN SCOTLAND LIMITED | 382219 | 509454 |
| DENSO MANUFACTURING CANADA INC | DENSO SALES THAILAND CO LIMITED | 847960 | 503636 |
| TECHVAST CORP | VESYNC SINGAPORE PRIVATE LIMITED | 847960 | 428023 |
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking